10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-013644`
Period End Date	20220630
Filing Date	20220815
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	bpth-20220630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 44 Cash Flow Statement 39 Stockholders Equity 22

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$23.77M	USD	Point-in-time
Cash	`Cash`	$17.02M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$2.15M	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$523.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.84M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.39M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$26.14M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.56M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	7.16M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	7.16M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	7.16M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.10M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	7.16M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$917.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$874.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$203.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$225.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$203.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$243.00K	USD	Point-in-time
Total Assets	`Assets`	$21.01M	USD	Point-in-time
Total Assets	`Assets`	$26.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$106.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$611.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$608.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$770.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$82.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$958.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.32M	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$168.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$153.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.11M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.49M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 7,160 and 7,160 shares issued and outstanding, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 7,160 and 7,160 shares issued and outstanding, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$103.54M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$103.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-77.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-84.03M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$25.46M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$22.32M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$31.37M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$29.75M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$19.52M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$15.07M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$21.01M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$26.57M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.02M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$760.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.95M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.85M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.05M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.16M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.42M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.24M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.37M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.81M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.26M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-3.01M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.26M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.81M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.37M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$1.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.37M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.25M	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.42	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.89	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.26	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.67	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.26	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.42	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.67	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.89	USD	2 Qtrs
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	6.96M	shares	1 Quarter
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	6.34M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.16M	shares	1 Quarter
Weighted average number of common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.16M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	6.34M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.16M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.16M	shares	1 Quarter
Weighted average number of common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	6.96M	shares	1 Quarter

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.37M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.25M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$430.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$329.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$42.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$45.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$43.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$36.00K	USD	2 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$1.62M	USD	2 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$263.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-451.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$82.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$14.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$343.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$46.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$50.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.73M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.22M	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.00K	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-21.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.00K	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.20M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$14.45M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$4.16M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.61M	USD	2 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.75M	USD	2 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.34M	USD	2 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.77M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.02M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.76M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.09M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.77M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.02M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.76M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.09M	USD	Point-in-time
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$85.00K	USD	2 Qtrs

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$25.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$22.32M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$31.37M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$29.75M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$19.52M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$15.07M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$14.45M	USD	2 Qtrs
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$4.16M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$329.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$213.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$430.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$189.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.37M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.25M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$25.46M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$22.32M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$31.37M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$29.75M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$19.52M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$15.07M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.